Dark Horse Consulting Group Inc.
Amanda Mack is an accomplished professional with extensive experience in stem cell biology and therapeutic applications. Currently serving as Principal at Dark Horse Consulting Group Inc. since July 2021, Amanda has previously held significant roles including Director of iPSC Biology and Process Optimization at Century Therapeutics, LLC, and various senior positions at FUJIFILM Cellular Dynamics, where responsibilities included leadership in PSC-derived cell therapies. Additionally, Amanda served as Director of iPSC Platforms for Ocular Therapies at Opsis Therapeutics. Amanda's academic credentials include a Ph.D. in Oncology/Cancer Research from the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison and a Bachelor of Applied Science from the University of North Carolina at Chapel Hill.
This person is not in any offices
Dark Horse Consulting Group Inc.
AT DARK HORSE CONSULTING, we work to accelerate cell and gene therapies through our unmatched expertise. Our consulting team has extensive CGT industry experience with knowledge spanning manufacturing, process development, comparability, analytical dev, quant modeling, quality systems, regulatory support, preclinical dev, device dev, program management, facility design and enginnering, market research, and due diligence and business strategy. Many of our consultants also bring experience from adjacent, more mature, sectors, including traditional biologics, small molecules, medical devices, and management consulting. Client requests range from scientific expertise to tactical needs to strategic considerations to business development. We understand the unique challenges faced by Cell and Gene Therapy developers like none other. We apply best practices from across this and other industries to address the needs of our clients, who range from biopharmaceutical companies to tools & tech providers to investment firms.